Frontier Biotechnologies Inc
688221
Company Profile
Business description
Frontier Biotechnologies Inc is an innovative biomedical company. It is engaged in the production and sales of innovative drugs for major unmet clinical needs. The company focuses on the research and development of new drugs in the field of long-acting peptides and differentiated product development strategies for unmet clinical and patient needs.
Contact
No. 5 Gande Road
7th Floor, Science Park
Jiangning District, Jiangsu Province
Nanjing211122
CHNT: +86 2569648375
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
302
Stocks News & Analysis
stocks
3 global ‘buy the dip’ candidates with wide moats
Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.
stocks
What next for Nine Entertainment after Domain payout?
The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,128.70 | 18.10 | 0.20% |
| CAC 40 | 7,784.21 | 39.31 | -0.50% |
| DAX 40 | 23,620.80 | 82.85 | -0.35% |
| Dow JONES (US) | 46,108.00 | 617.08 | 1.36% |
| FTSE 100 | 9,324.78 | 27.20 | 0.29% |
| HKSE | 26,388.16 | 301.84 | 1.16% |
| NASDAQ | 22,043.07 | 157.01 | 0.72% |
| Nikkei 225 | 44,768.12 | 395.62 | 0.89% |
| NZX 50 Index | 13,227.90 | 1.25 | -0.01% |
| S&P 500 | 6,587.47 | 55.43 | 0.85% |
| S&P/ASX 200 | 8,864.90 | 22.00 | 0.25% |
| SSE Composite Index | 3,870.60 | 4.71 | -0.12% |